May 23, 2018

Study examines treatment options for women with recurrent ovarian cancer

by Wiley

ovarian cancer
Intermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epithelium that pseudo-stratifies (left - diagnostic of a LMP tumour). Epithelium in a frond-like architecture is seen at the top of image. Credit: Nephron /Wikipedia. CC BY-SA 3.0

New research indicates that for women with advanced epithelial ovarian cancer whose cancer has relapsed after surgery, a second surgery is worth considering. The population-based registry study confirms the results suggested by a recent randomized trial.

In the Acta Obstetricia et Gynecologica Scandinavica study, secondary delayed a new recurrence for 2 years and resulted in at least 6 years median overall survival.

"Treatment for ovarian cancer is centralized to only a few hospitals in Norway. The favourable results may encourage other countries to adopt this model in order to treat more patients with secondary surgery at first recurrence," said lead author Dr. Witold Szczesny, of the Cancer Registry of Norway.

More information: Witold Szczesny et al, Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum-sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry-based study, Acta Obstetricia et Gynecologica Scandinavica (2018). DOI: 10.1111/aogs.13361

Journal information: Acta Obstetricia et Gynecologica Scandinavica
Provided by Wiley
Citation: Study examines treatment options for women with recurrent ovarian cancer (2018, May 23) retrieved 17 April 2024 from https://medicalxpress.com/news/2018-05-treatment-options-women-recurrent-ovarian.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Ovarian cancer is hard to detect
5 shares

Feedback to editors
Health improvements occurred worldwide since 2010 despite COVID-19 pandemic, but progress was uneven: Study

2 hours ago
Study shows heart failure, not stroke is the most common complication of atrial fibrillation

2 hours ago
Antipsychotics for dementia linked to more harms than previously acknowledged

2 hours ago
Protecting brain cells with cannabinol: Research suggests CBN shows promise for treating neurological disorders

2 hours ago
Calorie restriction study reveals complexities in how diet impacts aging

3 hours ago
Ketamine produces wide variety of responses in the brain, researchers find

3 hours ago
Emotional radio ads may ease listeners' qualms, boosting support for organ donation

4 hours ago
To understand cognition and its dysfunction, neuroscientists must learn its rhythms

4 hours ago
New insights into the mechanisms of bacterial brain invasion during meningitis

4 hours ago
Study finds lower relapse risk in triple-negative breast cancer with high immune cell levels

4 hours ago
Load comments (0)